H. O. Bang, J. Dyerberg, and N. Hjøorne, The composition of food consumed by Greenland Eskimos, Acta Med. Scand, vol.200, pp.69-73, 1976.

M. L. Burr, A. M. Fehily, J. F. Gilbert, S. Rogers, R. M. Holliday et al., Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART), Lancet, vol.2, pp.757-761, 1989.

D. S. Siscovick, T. E. Raghunathan, I. King, S. Weinmann, K. G. Wicklund et al., Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest, JAMA, vol.274, pp.1363-1367, 1995.

C. M. Albert, H. Campos, M. J. Stampfer, P. M. Ridker, J. E. Manson et al., Blood levels of long-chain n-3 fatty acids and the risk of sudden death, N. Engl. J. Med, vol.346, pp.1113-1118, 2002.

D. Mozaffarian, R. N. Lemaitre, L. H. Kuller, G. L. Burke, R. P. Tracy et al., Health Study. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study, Circulation, vol.107, pp.1372-1377, 2003.

, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, Lancet, vol.354, pp.447-455, 1999.

G. E. Billman, J. X. Kang, and A. Leaf, Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs, Circulation, vol.99, pp.2452-2457, 1999.

G. E. Billman, H. Hallaq, and A. Leaf, Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids, Proc. Natl. Acad. Sci. USA, vol.91, pp.4427-4430, 1994.

P. L. Mclennan, T. M. Bridle, M. Y. Abeywardena, and J. S. Charnock, Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey, Am. Heart J, vol.123, pp.1555-1561, 1992.

D. Mozaffarian, R. J. Prineas, P. K. Stein, and D. S. Siscovick, Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans, J. Am. Coll. Cardiol, vol.48, pp.478-484, 2006.

A. Leaf, J. X. Kang, and Y. Xiao, Fish oil fatty acids as cardiovascular drugs, Curr. Vasc. Pharmacol, vol.6, pp.1-12, 2008.

S. Judé, S. Bedut, S. Roger, M. Pinault, P. Champeroux et al., Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in rat ventricular myocytes, Br. J. Pharmacol, vol.139, pp.816-822, 2003.

Z. Zhao, H. Wen, N. Fefelova, C. Allen, N. Guillaume et al., Docosahexaenoic acid reduces the incidence of early afterdepolarizations caused by oxidative stress in rabbit ventricular myocytes, Front. Physiol, vol.3, p.252, 2012.

L. J. Roberts, T. J. Montine, W. R. Markesbery, A. R. Tapper, P. Hardy et al., Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid, J. Biol. Chem, vol.273, pp.13605-13612, 1998.

L. J. Roberts, J. P. Fessel, and S. S. Davies, The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation, Brain Pathol, vol.15, pp.143-148, 2005.

R. C. Seet, C. J. Lee, B. P. Chan, V. K. Sharma, H. Teoh et al., Oxidative damage in ischemic stroke revealed using multiple biomarkers, Stroke J. Cereb. Circ, vol.42, pp.2326-2329, 2011.

C. Gladine, J. W. Newman, T. Durand, T. L. Pedersen, J. Galano et al., Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention, PLoS One, vol.9, p.89393, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00952161

J. Thireau, S. Karam, J. Fauconnier, S. Roberge, C. Cassan et al., Functional evidence for an active role of B-type natriuretic peptide in cardiac remodelling and proarrhythmogenicity, Cardiovasc. Res, vol.95, pp.59-68, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01824325

P. J. Podrid, T. Fuchs, and R. Candinas, Role of the sympathetic nervous system in the genesis of ventricular arrhythmia, Circulation, vol.82, pp.103-113, 1990.

H. M. Den-ruijter, G. Berecki, A. O. Verkerk, D. Bakker, A. Baartscheer et al., Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure, Circulation, vol.117, pp.536-544, 2008.

C. Oger, Y. Brinkmann, S. Bouazzaoui, T. Durand, and J. Galano, Stereocontrolled access to isoprostanes via a bicyclo[3.3.0]octene framework, Org. Lett, vol.10, pp.5087-5090, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00744053

C. Oger, V. Bultel-poncé, A. Guy, L. Balas, J. Rossi et al., The handy use of Brown's P2-Ni catalyst for a skipped diyne deuteration: application to the synthesis of a, Chem. Eur. J, vol.16, pp.13976-13980, 2010.

A. Guy, C. Oger, J. Heppekausen, C. Signorini, C. De-felice et al., Oxygenated metabolites of n-3 polyunsaturated fatty acids as potential oxidative stress biomarkers: total synthesis of 8-F 3t-IsoP, 10F 4t-NeuroP and, Chem. Eur. J, vol.20, pp.6374-6380, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00996826

D. F. Taber, P. G. Reddy, and K. O. Arneson, A potential route to neuroprostanes and isoprostanes: preparation of the four enantiomerically pure diastereomers of 13-F4t-neuroP, J. Org. Chem, vol.73, pp.3467-3474, 2008.

E. Mas, F. Michel, A. Guy, V. Bultel, Y. Falquet et al., Quantification of urinary F2-isoprostanes with 4(RS)F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry: application to polytraumatized patients, J. Chromatogr. B Anal. Technol. Biomed. Life. Sci, vol.872, pp.133-140, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00319300

G. Berecki, H. M. ;-den-ruijter, A. O. Verkerk, C. A. Schumacher, A. Baartscheer et al., Dietary fish oil reduces the incidence of triggered arrhythmias in pig ventricular myocytes, Heart Rhythm, vol.4, pp.1452-1460, 2007.

G. W. Burton and K. U. Ingold, Vitamin E as an in vitro and in vivo antioxidant, Ann. N. Y. Acad. Sci, vol.570, pp.7-22, 1989.

D. R. Janero, D. Hreniuk, and H. M. Sharif, Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): lethal peroxidative membrane injury, J. Cell. Physiol, vol.149, pp.347-364, 1991.

O. Tarnavski, J. R. Mcmullen, M. Schinke, Q. Nie, S. Kong et al., Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies, Physiol. Genomics, vol.16, pp.349-360, 2004.

M. Hori and K. Nishida, Oxidative stress and left ventricular remodelling after myocardial infarction, Cardiovasc. Res, vol.81, pp.457-464, 2009.

R. Wang, Q. Chai, T. Lu, and H. Lee, Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity, Cardiovasc. Res, vol.90, pp.344-352, 2011.

A. De-la-torre, Y. Y. Lee, C. Oger, P. T. Sangild, T. Durand et al., Synthesis, discovery, and quantitation of dihomo-isofurans: biomarkers for in vivo adrenic acid peroxidation, Angew. Chem. Int. Ed. Engl, vol.53, pp.6249-6252, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01058061

A. De-la-torre, Y. Y. Lee, A. Mazzoni, A. Guy, V. Bultel-poncé et al., Total syntheses and in vivo quantitation of novel neurofuran and dihomo-isofuran derived from docosahexaenoic acid and adrenic acid, Chemistry, vol.21, pp.2442-2446, 2015.

R. Sankaranarayanan and L. Venetucci, Are the anti-arrhythmic effects of omega3 fatty acids due to modulation of myocardial calcium handling?, Front. Physiol, vol.3, p.373, 2012.

S. O. Marx, S. Reiken, Y. Hisamatsu, T. Jayaraman, D. Burkhoff et al., PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts, Cell, vol.101, pp.365-376, 2000.

J. Fauconnier, J. Thireau, S. Reiken, C. Cassan, S. Richard et al., Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy, Proc. Natl. Acad. Sci. USA, vol.107, pp.1559-1564, 2010.

J. Fauconnier, A. C. Meli, J. Thireau, S. Roberge, J. Shan et al., Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion, Proc. Natl. Acad. Sci. USA, vol.108, pp.13258-13263, 2011.

L. Xie and J. N. Weiss, Arrhythmogenic consequences of intracellular calcium waves, Am. J. Physiol. Heart Circ. Physiol, vol.297, pp.997-1002, 2009.

H. Cheng, W. J. Lederer, and M. B. Cannell, Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle, Science, vol.262, pp.740-744, 1993.

N. Negretti, M. R. Perez, D. ;. Walker, and S. C. O'neill, Inhibition of sarcoplasmic reticulum function by polyunsaturated fatty acids in intact, isolated myocytes from rat ventricular muscle, J. Physiol, vol.523, pp.367-375, 2000.

S. C. O'neill, M. R. Perez, K. E. Hammond, E. A. Sheader, and N. Negretti, Direct and indirect modulation of rat cardiac sarcoplasmic reticulum function by n-3 polyunsaturated fatty acids, J. Physiol, vol.538, pp.179-184, 2002.

R. Bolli, Causative role of oxyradicals in myocardial stunning: a proven hypothesis. A brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction, Basic Res. Cardiol, vol.93, pp.156-162, 1998.

J. M. Downey, Free radicals and their involvement during long-term myocardial ischemia and reperfusion, Annu. Rev. Physiol, vol.52, pp.487-504, 1990.

K. J. Davies, Protein damage and degradation by oxygen radicals. I. General aspects, J. Biol. Chem, vol.262, pp.9895-9901, 1987.

M. Dizdaroglu, Oxidative damage to DNA in mammalian chromatin, Mutat. Res, vol.275, pp.331-342, 1992.

K. P. Burton, A. C. Morris, K. D. Massey, L. M. Buja, and H. K. Hagler, Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes, J. Mol. Cell. Cardiol, vol.22, pp.1035-1047, 1990.

K. Fukuda, S. S. Davies, T. Nakajima, B. Ong, S. Kupershmidt et al., Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels, Circ. Res, vol.97, pp.1262-1269, 2005.

E. Jeong, M. Liu, M. Sturdy, G. Gao, S. T. Varghese et al., Metabolic stress, reactive oxygen species, and arrhythmia, J. Mol. Cell. Cardiol, vol.52, pp.454-463, 2012.

A. Leaf, Y. F. Xiao, J. X. Kang, and G. E. Billman, Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids, Pharmacol. Ther, vol.98, pp.355-377, 2003.

D. C. Andersson and A. R. Marks, Fixing ryanodine receptor Ca leak-a novel therapeutic strategy for contractile failure in heart and skeletal muscle, Drug Discovery Today Dis. Mech, vol.7, pp.151-157, 2010.

R. Schrepf, T. Limmert, P. Weber, K. Theisen, and A. Sellmayer, Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia, Lancet, vol.363, pp.1441-1442, 2004.

R. Marchioli, F. Barzi, E. Bomba, C. Chieffo, D. Gregorio et al., GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell, Infarto Miocardico (GISSI)Prevenzione. Circulation, vol.105, pp.1897-1903, 2002.

M. De-lorgeril, P. Salen, P. Defaye, and M. Rabaeus, Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?, BMC Med, vol.11, p.5, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00777776

V. Schacky and C. , Omega-3 index and sudden cardiac death, Nutrients, vol.2, pp.375-388, 2010.

P. Lu, M. L. Schrag, D. E. Slaughter, C. E. Raab, M. Shou et al., Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor, Drug Metab. Dispos. Biol. Fate Chem, vol.31, pp.1352-1360, 2003.

K. G. Peri, G. Almazan, D. R. Varma, and S. Chemtob, A role for protein kinase C alpha in stimulation of prostaglandin G/H synthase-2 transcription by 14,15epoxyeicosatrienoic acid, Biochem. Biophys. Res. Commun, vol.244, pp.96-101, 1998.

L. I. Brueggemann, A. R. Mackie, B. K. Mani, L. L. Cribbs, and K. L. Byron, Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles, Mol. Pharmacol, vol.76, pp.1053-1061, 2009.

J. D. Imig and B. D. Hammock, Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases, Nat. Rev. Drug Discovery, vol.8, pp.794-805, 2009.